| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.05e-10 | 188 | 69 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 EYS FBN1 MEGF6 MEGF8 DLL3 LRP1 LRP2 DLK2 DGKA LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 3.06e-08 | 749 | 69 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 2.40e-06 | 175 | 69 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 9.80e-06 | 39 | 69 | 4 | GO:0070325 | |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 RELN FBN1 TNC LAMA1 LAMA3 LAMA5 LAMC3 LTBP4 SSPOP FBN3 OTOG | 4.88e-05 | 891 | 69 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | zinc ion binding | ZMYND11 RCHY1 RNF112 TUT7 NFX1 TRIM8 AIRE UHRF1 ADAM33 SLC39A4 ZNFX1 TRIM14 | 4.88e-05 | 891 | 69 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.11e-04 | 599 | 69 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.93e-04 | 562 | 69 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ZMYND11 RCHY1 RNF112 TUT7 NFX1 TRIM8 AIRE UHRF1 ADAM33 SLC39A4 ZNFX1 TRIM14 | 7.06e-04 | 1189 | 69 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.18e-03 | 229 | 69 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 1.22e-03 | 473 | 69 | 7 | GO:0004842 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.34e-03 | 775 | 69 | 9 | GO:0016746 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.37e-03 | 16 | 69 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.79e-03 | 372 | 69 | 6 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.91e-03 | 512 | 69 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.37e-03 | 21 | 69 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 2.37e-03 | 532 | 69 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.51e-03 | 398 | 69 | 6 | GO:0061659 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 3.63e-03 | 26 | 69 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 3.63e-03 | 26 | 69 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | Notch binding | 3.91e-03 | 27 | 69 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | axon guidance | SEMA3F HSPG2 RELN MEGF8 LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 3.04e-09 | 285 | 70 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | SEMA3F HSPG2 RELN MEGF8 LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 3.15e-09 | 286 | 70 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | axon development | SEMA3F HSPG2 RELN MEGF8 TNC TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 2.12e-07 | 642 | 70 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA3F HSPG2 RELN MEGF8 TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 4.05e-07 | 566 | 70 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.18e-06 | 410 | 70 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA3F HSPG2 RELN MEGF8 TNC TNN PLA2G3 LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 PLD2 NOTCH3 OTOG | 4.74e-06 | 1285 | 70 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | SEMA3F HSPG2 RELN MEGF8 TNC TNN PLA2G3 LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 PLD2 NOTCH3 CRB1 OTOG | 5.67e-06 | 1463 | 70 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA3F HSPG2 RELN MEGF8 TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 7.31e-06 | 748 | 70 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA3F HSPG2 RELN MEGF8 TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 1.47e-05 | 802 | 70 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA3F HSPG2 RELN MEGF8 TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 1.81e-05 | 819 | 70 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA3F HSPG2 RELN MEGF8 TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 | 1.97e-05 | 826 | 70 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 2.17e-05 | 99 | 70 | 5 | GO:0045995 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 3.31e-05 | 108 | 70 | 5 | GO:0007044 | |
| GeneOntologyBiologicalProcess | positive regulation of dermatome development | 3.40e-05 | 3 | 70 | 2 | GO:0061184 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.61e-05 | 270 | 70 | 7 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 4.48e-05 | 115 | 70 | 5 | GO:0150115 | |
| GeneOntologyBiologicalProcess | dermatome development | 6.78e-05 | 4 | 70 | 2 | GO:0061054 | |
| GeneOntologyBiologicalProcess | regulation of dermatome development | 6.78e-05 | 4 | 70 | 2 | GO:0061183 | |
| GeneOntologyBiologicalProcess | cell junction organization | SEMA3F RELN TRIP6 TNC LRP1 LAMA3 LAMA5 WNT4 AJUBA ZDHHC8 SVEP1 LIMS2 | 9.72e-05 | 974 | 70 | 12 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.13e-04 | 5 | 70 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.13e-04 | 5 | 70 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | SEMA3F RELN MEGF8 TRIP6 TNC TNN LAMA1 LRP1 LAMA3 AIRE LAMA5 WNT4 PLD2 AJUBA | 1.25e-04 | 1327 | 70 | 14 | GO:0040012 |
| GeneOntologyBiologicalProcess | embryonic brain development | 1.28e-04 | 29 | 70 | 3 | GO:1990403 | |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 1.44e-04 | 78 | 70 | 4 | GO:0051865 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA3F HSPG2 RELN MEGF8 TNN LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 NOTCH3 CRB1 | 1.66e-04 | 1194 | 70 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | trunk neural crest cell migration | 1.69e-04 | 6 | 70 | 2 | GO:0036484 | |
| GeneOntologyBiologicalProcess | trunk segmentation | 1.69e-04 | 6 | 70 | 2 | GO:0035290 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | SEMA3F RELN TRIP6 TNC TNN LAMA1 LRP1 LAMA3 AIRE LAMA5 WNT4 PLD2 AJUBA | 1.91e-04 | 1211 | 70 | 13 | GO:0030334 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 2.36e-04 | 7 | 70 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.37e-04 | 619 | 70 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 2.71e-04 | 927 | 70 | 11 | GO:0030155 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.71e-04 | 92 | 70 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | bone development | 2.74e-04 | 264 | 70 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | embryo development | SEMA3F HSPG2 KMT2D MEGF8 TRIP6 WNT1 RNF112 DLL3 LAMA1 NR0B1 LRP2 LAMA3 LAMA5 WNT4 | 2.87e-04 | 1437 | 70 | 14 | GO:0009790 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 MEGF8 TNC NSD2 WNT1 LAMA1 LRP2 LAMA3 LAMA5 LAMC3 WNT4 CRB1 LIMS2 | 3.02e-04 | 1269 | 70 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of cell motility | SEMA3F RELN TRIP6 TNC TNN LAMA1 LRP1 LAMA3 AIRE LAMA5 WNT4 PLD2 AJUBA | 3.28e-04 | 1280 | 70 | 13 | GO:2000145 |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 3.32e-04 | 97 | 70 | 4 | GO:0048041 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 3.38e-04 | 40 | 70 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 3.48e-04 | 178 | 70 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 3.64e-04 | 41 | 70 | 3 | GO:0046473 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 4.18e-04 | 103 | 70 | 4 | GO:0048525 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 5.57e-04 | 421 | 70 | 7 | GO:0060562 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 5.66e-04 | 198 | 70 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | gland development | 5.90e-04 | 558 | 70 | 8 | GO:0048732 | |
| GeneOntologyBiologicalProcess | gliogenesis | 6.75e-04 | 435 | 70 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 7.33e-04 | 12 | 70 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 7.70e-04 | 321 | 70 | 6 | GO:0010001 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 7.72e-04 | 445 | 70 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 8.40e-04 | 124 | 70 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 9.47e-04 | 750 | 70 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.01e-03 | 14 | 70 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.01e-03 | 14 | 70 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | artery development | 1.09e-03 | 133 | 70 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.11e-03 | 615 | 70 | 8 | GO:0001501 | |
| GeneOntologyBiologicalProcess | regionalization | 1.17e-03 | 478 | 70 | 7 | GO:0003002 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.23e-03 | 482 | 70 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cell growth | 1.23e-03 | 625 | 70 | 8 | GO:0016049 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.24e-03 | 236 | 70 | 5 | GO:0061138 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.28e-03 | 354 | 70 | 6 | GO:0050769 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.35e-03 | 1125 | 70 | 11 | GO:0035239 | |
| GeneOntologyCellularComponent | extracellular matrix | CCN5 HSPG2 RELN EYS FBN1 MEGF6 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 WNT4 LTBP4 SSPOP FBN3 SVEP1 OTOG | 4.55e-12 | 656 | 71 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CCN5 HSPG2 RELN EYS FBN1 MEGF6 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 WNT4 LTBP4 SSPOP FBN3 SVEP1 OTOG | 4.79e-12 | 658 | 71 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 RELN EYS FBN1 MEGF6 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 LTBP4 SSPOP | 2.34e-08 | 530 | 71 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.89e-07 | 122 | 71 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 4.43e-06 | 10 | 71 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | microfibril | 1.05e-05 | 13 | 71 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.47e-05 | 17 | 71 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin-3 complex | 3.40e-05 | 3 | 71 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin-5 complex | 6.79e-05 | 4 | 71 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | tenascin complex | 6.79e-05 | 4 | 71 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.26e-04 | 443 | 71 | 8 | GO:0030055 | |
| GeneOntologyCellularComponent | focal adhesion | 6.44e-04 | 431 | 71 | 7 | GO:0005925 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 8.66e-04 | 13 | 71 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.07e-03 | 59 | 71 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | anchoring junction | 1.63e-03 | 976 | 71 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.94e-03 | 384 | 71 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | apical part of cell | 3.92e-03 | 592 | 71 | 7 | GO:0045177 | |
| HumanPheno | Abnormality of external features of the abdomen | HSPG2 KMT2D FBN1 MEGF8 DLL3 TRIM8 LRP2 UHRF1 LTBP4 NOTCH3 DNMT3A | 8.79e-06 | 326 | 36 | 11 | HP:0001462 |
| HumanPheno | Umbilical hernia | 3.31e-05 | 306 | 36 | 10 | HP:0001537 | |
| HumanPheno | Abnormal umbilicus morphology | 4.02e-05 | 313 | 36 | 10 | HP:0001551 | |
| HumanPheno | Abnormality of the diaphragm | 4.57e-05 | 141 | 36 | 7 | HP:0000775 | |
| HumanPheno | Congenital diaphragmatic hernia | 5.95e-05 | 100 | 36 | 6 | HP:0000776 | |
| HumanPheno | Hernia | HSPG2 KMT2D FBN1 MEGF8 NSD2 DLL3 TRIM8 LRP2 UHRF1 WNT4 LTBP4 NOTCH3 DNMT3A | 1.07e-04 | 589 | 36 | 13 | HP:0100790 |
| MousePheno | abnormal cranium morphology | HSPG2 KMT2D FBN1 CLCN5 MEGF8 TRIP6 NSD2 WNT1 TNN DLL3 LRP2 LAMA3 LAMA5 | 4.62e-05 | 813 | 62 | 13 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | HSPG2 KMT2D FBN1 CLCN5 MEGF8 TRIP6 NSD2 WNT1 TNN DLL3 LRP2 LAMA3 LAMA5 | 5.50e-05 | 827 | 62 | 13 | MP:0002116 |
| MousePheno | increased urine microglobulin level | 5.79e-05 | 3 | 62 | 2 | MP:0011555 | |
| MousePheno | abnormal craniofacial morphology | HSPG2 ZMYND11 KMT2D FBN1 CLCN5 MEGF8 TRIP6 NSD2 WNT1 TNN DLL3 LRP1 LRP2 LAMA3 LAMA5 UHRF1 SLC39A4 | 6.70e-05 | 1372 | 62 | 17 | MP:0000428 |
| MousePheno | craniofacial phenotype | HSPG2 ZMYND11 KMT2D FBN1 CLCN5 MEGF8 TRIP6 NSD2 WNT1 TNN DLL3 LRP1 LRP2 LAMA3 LAMA5 UHRF1 SLC39A4 | 6.70e-05 | 1372 | 62 | 17 | MP:0005382 |
| MousePheno | abnormal jaw morphology | 1.03e-04 | 530 | 62 | 10 | MP:0000454 | |
| MousePheno | abnormal axial skeleton morphology | HSPG2 ZMYND11 KMT2D FBN1 CLCN5 MEGF8 TRIP6 NSD2 WNT1 TNN DLL3 LRP2 LAMA3 LAMA5 LTBP4 SSPOP NOTCH3 | 1.43e-04 | 1458 | 62 | 17 | MP:0002114 |
| Domain | EGF-like_dom | HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LAMA1 LRP1 LRP2 DLK2 LAMA3 LAMA5 ADAM33 LAMC3 C7 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 OTOG | 9.84e-28 | 249 | 71 | 24 | IPR000742 |
| Domain | EGF_1 | HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LAMA1 LRP1 LRP2 DLK2 LAMA3 LAMA5 ADAM33 LAMC3 C7 LTBP4 SSPOP FBN3 SVEP1 NOTCH3 CRB1 | 1.77e-27 | 255 | 71 | 24 | PS00022 |
| Domain | EGF_2 | HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LAMA1 LRP1 LRP2 DLK2 LAMA3 LAMA5 ADAM33 LAMC3 C7 LTBP4 SSPOP FBN3 SVEP1 NOTCH3 CRB1 | 4.53e-27 | 265 | 71 | 24 | PS01186 |
| Domain | EGF-like_CS | HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LAMA1 LRP1 LRP2 DLK2 LAMA3 LAMA5 ADAM33 LAMC3 C7 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 1.21e-25 | 261 | 71 | 23 | IPR013032 |
| Domain | Growth_fac_rcpt_ | CCN5 HSPG2 EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LAMA1 LRP1 LRP2 LAMA3 LAMA5 LAMC3 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 1.22e-25 | 156 | 71 | 20 | IPR009030 |
| Domain | EGF | HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LAMA1 LRP1 LRP2 DLK2 LAMA3 LAMA5 ADAM33 LAMC3 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 4.17e-25 | 235 | 71 | 22 | SM00181 |
| Domain | EGF_3 | HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC TNN DLL3 LRP1 LRP2 DLK2 ADAM33 C7 LTBP4 SSPOP FBN3 SVEP1 NOTCH3 CRB1 OTOG | 1.58e-23 | 235 | 71 | 21 | PS50026 |
| Domain | EGF_CA | HSPG2 EYS FBN1 MEGF6 MEGF8 DLL3 LRP1 LRP2 DLK2 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 2.11e-17 | 122 | 71 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 EYS FBN1 MEGF6 MEGF8 DLL3 LRP1 LRP2 DLK2 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 2.66e-17 | 124 | 71 | 14 | IPR001881 |
| Domain | EGF_Ca-bd_CS | EYS FBN1 MEGF6 MEGF8 LRP1 LRP2 DLK2 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 1.90e-15 | 97 | 71 | 12 | IPR018097 |
| Domain | EGF_CA | EYS FBN1 MEGF6 MEGF8 LRP1 LRP2 DLK2 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 2.45e-15 | 99 | 71 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | EYS FBN1 MEGF6 MEGF8 LRP1 LRP2 DLK2 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 2.77e-15 | 100 | 71 | 12 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | EYS FBN1 MEGF6 MEGF8 LRP1 LRP2 DLK2 LTBP4 FBN3 SVEP1 NOTCH3 CRB1 | 5.71e-15 | 106 | 71 | 12 | IPR000152 |
| Domain | EGF_extracell | 2.11e-14 | 60 | 71 | 10 | IPR013111 | |
| Domain | EGF_2 | 2.11e-14 | 60 | 71 | 10 | PF07974 | |
| Domain | EGF | HSPG2 EYS MEGF6 TNC DLL3 LRP1 LRP2 DLK2 FBN3 SVEP1 NOTCH3 CRB1 | 4.76e-14 | 126 | 71 | 12 | PF00008 |
| Domain | hEGF | 8.49e-14 | 28 | 71 | 8 | PF12661 | |
| Domain | EGF_CA | 3.58e-11 | 86 | 71 | 9 | PF07645 | |
| Domain | LAMININ_IVA | 3.82e-11 | 8 | 71 | 5 | PS51115 | |
| Domain | Laminin_B | 3.82e-11 | 8 | 71 | 5 | PF00052 | |
| Domain | LamB | 3.82e-11 | 8 | 71 | 5 | SM00281 | |
| Domain | Laminin_IV | 3.82e-11 | 8 | 71 | 5 | IPR000034 | |
| Domain | Laminin_EGF | 5.23e-11 | 35 | 71 | 7 | PF00053 | |
| Domain | EGF_Lam | 5.23e-11 | 35 | 71 | 7 | SM00180 | |
| Domain | Laminin_EGF | 9.73e-11 | 38 | 71 | 7 | IPR002049 | |
| Domain | EGF_LAM_2 | 1.34e-09 | 30 | 71 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 1.34e-09 | 30 | 71 | 6 | PS01248 | |
| Domain | LAM_G_DOMAIN | 6.10e-09 | 38 | 71 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 8.43e-09 | 40 | 71 | 6 | PF02210 | |
| Domain | LamG | 1.53e-08 | 44 | 71 | 6 | SM00282 | |
| Domain | Znf_PHD-finger | 1.98e-08 | 79 | 71 | 7 | IPR019787 | |
| Domain | - | 7.18e-08 | 95 | 71 | 7 | 2.60.120.200 | |
| Domain | Laminin_G | 8.42e-08 | 58 | 71 | 6 | IPR001791 | |
| Domain | Laminin_N | 3.37e-07 | 16 | 71 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 3.37e-07 | 16 | 71 | 4 | PS51117 | |
| Domain | Laminin_N | 3.37e-07 | 16 | 71 | 4 | PF00055 | |
| Domain | LamNT | 3.37e-07 | 16 | 71 | 4 | SM00136 | |
| Domain | PHD | 3.98e-07 | 75 | 71 | 6 | PF00628 | |
| Domain | LDLR_class-A_CS | 4.08e-07 | 40 | 71 | 5 | IPR023415 | |
| Domain | Laminin_aI | 5.24e-07 | 5 | 71 | 3 | IPR009254 | |
| Domain | Laminin_I | 5.24e-07 | 5 | 71 | 3 | PF06008 | |
| Domain | Laminin_II | 5.24e-07 | 5 | 71 | 3 | PF06009 | |
| Domain | Laminin_domII | 5.24e-07 | 5 | 71 | 3 | IPR010307 | |
| Domain | Ldl_recept_a | 7.47e-07 | 45 | 71 | 5 | PF00057 | |
| Domain | - | 8.36e-07 | 46 | 71 | 5 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.04e-06 | 48 | 71 | 5 | PS01209 | |
| Domain | PHD | 1.10e-06 | 89 | 71 | 6 | SM00249 | |
| Domain | LDLRA_2 | 1.15e-06 | 49 | 71 | 5 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.15e-06 | 49 | 71 | 5 | IPR002172 | |
| Domain | LDLa | 1.15e-06 | 49 | 71 | 5 | SM00192 | |
| Domain | Znf_PHD | 1.26e-06 | 91 | 71 | 6 | IPR001965 | |
| Domain | Znf_FYVE_PHD | 1.42e-06 | 147 | 71 | 7 | IPR011011 | |
| Domain | ZF_PHD_2 | 1.62e-06 | 95 | 71 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.72e-06 | 96 | 71 | 6 | PS01359 | |
| Domain | ConA-like_dom | 1.77e-06 | 219 | 71 | 8 | IPR013320 | |
| Domain | TB | 1.82e-06 | 7 | 71 | 3 | PF00683 | |
| Domain | RING | 2.25e-06 | 305 | 71 | 9 | SM00184 | |
| Domain | cEGF | 2.69e-06 | 26 | 71 | 4 | IPR026823 | |
| Domain | cEGF | 2.69e-06 | 26 | 71 | 4 | PF12662 | |
| Domain | - | 2.91e-06 | 8 | 71 | 3 | 3.90.290.10 | |
| Domain | Znf_RING | 3.88e-06 | 326 | 71 | 9 | IPR001841 | |
| Domain | TB | 4.35e-06 | 9 | 71 | 3 | PS51364 | |
| Domain | TB_dom | 4.35e-06 | 9 | 71 | 3 | IPR017878 | |
| Domain | Zinc_finger_PHD-type_CS | 4.76e-06 | 65 | 71 | 5 | IPR019786 | |
| Domain | - | RNF169 ZMYND11 KMT2D RCHY1 NSD2 RNF112 TRIM8 AIRE UHRF1 SP110 | 7.26e-06 | 449 | 71 | 10 | 3.30.40.10 |
| Domain | Laminin_G_1 | 8.50e-06 | 11 | 71 | 3 | PF00054 | |
| Domain | Znf_RING/FYVE/PHD | RNF169 ZMYND11 KMT2D RCHY1 NSD2 RNF112 TRIM8 AIRE UHRF1 SP110 | 8.80e-06 | 459 | 71 | 10 | IPR013083 |
| Domain | TIL_dom | 1.86e-05 | 14 | 71 | 3 | IPR002919 | |
| Domain | ZnF_NFX | 4.26e-05 | 3 | 71 | 2 | SM00438 | |
| Domain | zf-NF-X1 | 4.26e-05 | 3 | 71 | 2 | PF01422 | |
| Domain | Znf_NFX1 | 4.26e-05 | 3 | 71 | 2 | IPR000967 | |
| Domain | FBN | 4.26e-05 | 3 | 71 | 2 | IPR011398 | |
| Domain | PWWP | 5.73e-05 | 20 | 71 | 3 | SM00293 | |
| Domain | PWWP | 8.83e-05 | 23 | 71 | 3 | PF00855 | |
| Domain | PWWP_dom | 8.83e-05 | 23 | 71 | 3 | IPR000313 | |
| Domain | PWWP | 1.01e-04 | 24 | 71 | 3 | PS50812 | |
| Domain | ZF_RING_1 | 1.18e-04 | 291 | 71 | 7 | PS00518 | |
| Domain | ZF_RING_2 | 1.36e-04 | 298 | 71 | 7 | PS50089 | |
| Domain | LIM | 1.38e-04 | 69 | 71 | 4 | PF00412 | |
| Domain | HSR | 1.41e-04 | 5 | 71 | 2 | PS51414 | |
| Domain | HSR | 1.41e-04 | 5 | 71 | 2 | PF03172 | |
| Domain | HSR_dom | 1.41e-04 | 5 | 71 | 2 | IPR004865 | |
| Domain | MCT | 1.41e-04 | 5 | 71 | 2 | IPR004743 | |
| Domain | - | 1.45e-04 | 70 | 71 | 4 | 2.10.110.10 | |
| Domain | Znf_LIM | 1.54e-04 | 71 | 71 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.54e-04 | 71 | 71 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.54e-04 | 71 | 71 | 4 | PS50023 | |
| Domain | LIM | 1.54e-04 | 71 | 71 | 4 | SM00132 | |
| Domain | SAND_dom | 3.93e-04 | 8 | 71 | 2 | IPR000770 | |
| Domain | SAND | 3.93e-04 | 8 | 71 | 2 | PF01342 | |
| Domain | SAND | 3.93e-04 | 8 | 71 | 2 | PS50864 | |
| Domain | SAND | 3.93e-04 | 8 | 71 | 2 | SM00258 | |
| Domain | Galactose-bd-like | 4.52e-04 | 94 | 71 | 4 | IPR008979 | |
| Domain | VWF_dom | 5.43e-04 | 42 | 71 | 3 | IPR001007 | |
| Domain | SET_dom | 9.08e-04 | 50 | 71 | 3 | IPR001214 | |
| Domain | SET | 9.08e-04 | 50 | 71 | 3 | PS50280 | |
| Domain | TIL | 9.18e-04 | 12 | 71 | 2 | PF01826 | |
| Domain | - | 9.18e-04 | 12 | 71 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 9.18e-04 | 12 | 71 | 2 | IPR010919 | |
| Domain | C8 | 9.18e-04 | 12 | 71 | 2 | PF08742 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.27e-09 | 84 | 56 | 8 | M7098 | |
| Pathway | WP_FOCAL_ADHESION | 7.93e-08 | 199 | 56 | 9 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.93e-08 | 199 | 56 | 9 | M7253 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.09e-07 | 30 | 56 | 5 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.14e-07 | 59 | 56 | 6 | M27218 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.46e-07 | 300 | 56 | 10 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.27e-07 | 76 | 56 | 6 | M27219 | |
| Pathway | WP_FOCAL_ADHESION | 6.80e-07 | 187 | 56 | 8 | MM15913 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.67e-06 | 30 | 56 | 4 | M27772 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.13e-06 | 66 | 56 | 5 | M18 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 9.58e-06 | 11 | 56 | 3 | M158 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.03e-05 | 41 | 56 | 4 | M27778 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.22e-05 | 46 | 56 | 4 | M239 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 5.24e-05 | 439 | 56 | 9 | M42563 | |
| Pathway | WP_CANCER_PATHWAYS | 1.57e-04 | 507 | 56 | 9 | M48302 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.62e-04 | 27 | 56 | 3 | M39545 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.82e-04 | 302 | 56 | 7 | M39719 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.29e-04 | 140 | 56 | 5 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.69e-04 | 79 | 56 | 4 | M27643 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.71e-04 | 32 | 56 | 3 | M165 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.91e-04 | 326 | 56 | 7 | MM15917 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.98e-04 | 33 | 56 | 3 | M39503 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.40e-04 | 84 | 56 | 4 | M3228 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 3.55e-04 | 154 | 56 | 5 | M39739 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.68e-04 | 339 | 56 | 7 | M39736 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.19e-04 | 37 | 56 | 3 | M27134 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 4.27e-04 | 8 | 56 | 2 | M47850 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.66e-04 | 96 | 56 | 4 | M39834 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.01e-04 | 44 | 56 | 3 | M26969 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 9.05e-04 | 48 | 56 | 3 | M27642 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.18e-03 | 13 | 56 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.18e-03 | 13 | 56 | 2 | M47534 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.22e-03 | 118 | 56 | 4 | M39852 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 1.42e-03 | 56 | 56 | 3 | M1053 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 1.57e-03 | 15 | 56 | 2 | M27273 | |
| Pathway | PID_NOTCH_PATHWAY | 1.65e-03 | 59 | 56 | 3 | M17 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.77e-03 | 325 | 56 | 6 | M12868 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 2.03e-03 | 17 | 56 | 2 | M39525 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.28e-03 | 66 | 56 | 3 | MM15925 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 2.54e-03 | 19 | 56 | 2 | M47836 | |
| Pubmed | 3.29e-12 | 175 | 72 | 10 | 28071719 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 9.75e-11 | 15 | 72 | 5 | 15895400 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.10e-09 | 26 | 72 | 5 | 34189436 | |
| Pubmed | HSPG2 MEGF6 MEGF8 TRIP6 RCHY1 NR0B1 LRP2 ADAM33 AJUBA LTBP4 SSPOP ZYX | 4.33e-09 | 608 | 72 | 12 | 16713569 | |
| Pubmed | 5.31e-09 | 118 | 72 | 7 | 21078624 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 5.51e-09 | 11 | 72 | 4 | 21524702 | |
| Pubmed | 8.25e-09 | 12 | 72 | 4 | 16750824 | ||
| Pubmed | 3.01e-08 | 16 | 72 | 4 | 17601529 | ||
| Pubmed | 4.24e-08 | 46 | 72 | 5 | 20301533 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.82e-08 | 248 | 72 | 8 | 24006456 | |
| Pubmed | 5.05e-08 | 18 | 72 | 4 | 11311202 | ||
| Pubmed | 5.88e-08 | 167 | 72 | 7 | 22159717 | ||
| Pubmed | 6.51e-08 | 50 | 72 | 5 | 23658023 | ||
| Pubmed | 7.98e-08 | 20 | 72 | 4 | 22911573 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 11969289 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 8.48e-08 | 5 | 72 | 3 | 9415429 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 8.48e-08 | 5 | 72 | 3 | 9389447 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 11829758 | ||
| Pubmed | 9.84e-08 | 21 | 72 | 4 | 17943183 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 9597096 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 15668394 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 2.07e-07 | 25 | 72 | 4 | 19373938 | |
| Pubmed | 2.44e-07 | 26 | 72 | 4 | 24742657 | ||
| Pubmed | 3.86e-07 | 29 | 72 | 4 | 22613833 | ||
| Pubmed | 3.87e-07 | 71 | 72 | 5 | 33541421 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 4.73e-07 | 8 | 72 | 3 | 23055981 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 4.73e-07 | 8 | 72 | 3 | 9489770 | |
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 19633172 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 8872465 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 9852162 | ||
| Pubmed | 6.14e-07 | 146 | 72 | 6 | 27068509 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.61e-07 | 79 | 72 | 5 | 18757743 | |
| Pubmed | 7.08e-07 | 9 | 72 | 3 | 9882526 | ||
| Pubmed | Laminin γ1 C-terminal Glu to Gln mutation induces early postimplantation lethality. | 7.08e-07 | 9 | 72 | 3 | 30456378 | |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 7.08e-07 | 9 | 72 | 3 | 18570250 | |
| Pubmed | 8.42e-07 | 35 | 72 | 4 | 19185060 | ||
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 11784026 | ||
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 9034910 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.01e-06 | 10 | 72 | 3 | 16100707 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 1.01e-06 | 10 | 72 | 3 | 16554364 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.39e-06 | 11 | 72 | 3 | 23472759 | |
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 12051813 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.84e-06 | 97 | 72 | 5 | 27559042 | |
| Pubmed | 1.85e-06 | 12 | 72 | 3 | 10433923 | ||
| Pubmed | 1.85e-06 | 12 | 72 | 3 | 9396756 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.24e-06 | 101 | 72 | 5 | 20551380 | |
| Pubmed | Loss of migfilin expression has no overt consequences on murine development and homeostasis. | 2.40e-06 | 13 | 72 | 3 | 21224394 | |
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 2.40e-06 | 13 | 72 | 3 | 21900571 | |
| Pubmed | 2.40e-06 | 13 | 72 | 3 | 22286099 | ||
| Pubmed | 2.40e-06 | 13 | 72 | 3 | 12682087 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F HSPG2 KMT2D SLC16A5 MEGF6 MEGF8 NSD2 NFX1 LAMA5 LAMC3 LTBP4 ZDHHC8 | 2.64e-06 | 1105 | 72 | 12 | 35748872 |
| Pubmed | 3.05e-06 | 14 | 72 | 3 | 9151674 | ||
| Pubmed | 3.05e-06 | 14 | 72 | 3 | 19783738 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 38537630 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 9264260 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28901428 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28976982 | ||
| Pubmed | The laminin response in inflammatory bowel disease: protection or malignancy? | 4.23e-06 | 2 | 72 | 2 | 25347196 | |
| Pubmed | Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2. | 4.23e-06 | 2 | 72 | 2 | 28659595 | |
| Pubmed | Retinoic acid inhibits adipogenesis via activation of Wnt signaling pathway in 3T3-L1 preadipocytes. | 4.23e-06 | 2 | 72 | 2 | 23583383 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20019771 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 11920562 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 4.23e-06 | 2 | 72 | 2 | 24484584 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 33103447 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17369355 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24101721 | ||
| Pubmed | Microfibrils at basement membrane zones interact with perlecan via fibrillin-1. | 4.23e-06 | 2 | 72 | 2 | 15657057 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 34445520 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28544784 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12382139 | ||
| Pubmed | Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. | 4.23e-06 | 2 | 72 | 2 | 32616814 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23104139 | ||
| Pubmed | Biological function of laminin-5 and pathogenic impact of its deficiency. | 4.23e-06 | 2 | 72 | 2 | 17000025 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15221638 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 38545339 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22211116 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 32514132 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 8601594 | ||
| Pubmed | 4.67e-06 | 16 | 72 | 3 | 30579834 | ||
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 4.67e-06 | 16 | 72 | 3 | 21067603 | |
| Pubmed | 4.67e-06 | 16 | 72 | 3 | 16880404 | ||
| Pubmed | 5.06e-06 | 210 | 72 | 6 | 16537572 | ||
| Pubmed | 6.33e-06 | 808 | 72 | 10 | 20412781 | ||
| Pubmed | 6.79e-06 | 18 | 72 | 3 | 15944199 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 6.79e-06 | 18 | 72 | 3 | 39040056 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.29e-06 | 135 | 72 | 5 | 28675934 | |
| Pubmed | 9.76e-06 | 64 | 72 | 4 | 22261194 | ||
| Pubmed | 1.10e-05 | 21 | 72 | 3 | 27856617 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 1.10e-05 | 21 | 72 | 3 | 22767514 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 10620696 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 11956231 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 9753670 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31548351 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 21926402 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 24324066 | ||
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 1.27e-05 | 3 | 72 | 2 | 9006922 | |
| Pubmed | Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. | 1.27e-05 | 3 | 72 | 2 | 12393739 | |
| Pubmed | α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals. | 1.27e-05 | 3 | 72 | 2 | 22761447 | |
| Pubmed | Obstructed migration of Purkinje cells in the developing cerebellum of the reeler mutant mouse. | 1.27e-05 | 3 | 72 | 2 | 7506500 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 25270072 | ||
| Interaction | HOXA1 interactions | CCN5 IGFN1 FBN1 MEGF6 MEGF8 TRIP6 RCHY1 TRIM8 LAMA5 LTBP4 NOTCH3 LIMS2 | 3.86e-09 | 356 | 71 | 12 | int:HOXA1 |
| Interaction | FBXO2 interactions | HSPG2 FBN1 MEGF8 LAMA1 LRP2 LAMA3 LAMA5 ADAM33 LAMC3 LTBP4 NOTCH3 | 1.90e-07 | 411 | 71 | 11 | int:FBXO2 |
| Interaction | ATN1 interactions | 3.06e-07 | 187 | 71 | 8 | int:ATN1 | |
| Interaction | GFI1B interactions | 5.06e-07 | 136 | 71 | 7 | int:GFI1B | |
| Interaction | MFAP5 interactions | 1.07e-06 | 52 | 71 | 5 | int:MFAP5 | |
| Interaction | NTN5 interactions | 1.42e-06 | 24 | 71 | 4 | int:NTN5 | |
| Interaction | ZFP41 interactions | 1.71e-06 | 57 | 71 | 5 | int:ZFP41 | |
| Interaction | IGFL3 interactions | 6.70e-06 | 75 | 71 | 5 | int:IGFL3 | |
| Interaction | ZNF408 interactions | 1.22e-05 | 145 | 71 | 6 | int:ZNF408 | |
| Interaction | ATXN7 interactions | 4.14e-05 | 109 | 71 | 5 | int:ATXN7 | |
| Interaction | CACNA1A interactions | 7.36e-05 | 123 | 71 | 5 | int:CACNA1A | |
| Interaction | ZDHHC15 interactions | 7.95e-05 | 125 | 71 | 5 | int:ZDHHC15 | |
| Interaction | FBLN2 interactions | 8.64e-05 | 66 | 71 | 4 | int:FBLN2 | |
| Interaction | SFRP1 interactions | 9.12e-05 | 25 | 71 | 3 | int:SFRP1 | |
| Interaction | MBD1 interactions | 1.58e-04 | 77 | 71 | 4 | int:MBD1 | |
| Cytoband | 7q22 | 1.64e-03 | 38 | 72 | 2 | 7q22 | |
| Cytoband | 12q13.3 | 2.94e-03 | 51 | 72 | 2 | 12q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 3.13e-03 | 185 | 72 | 3 | chr7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.46e-03 | 423 | 72 | 4 | chr12q13 | |
| GeneFamily | PHD finger proteins | 1.46e-08 | 90 | 58 | 7 | 88 | |
| GeneFamily | Laminin subunits | 4.63e-08 | 12 | 58 | 4 | 626 | |
| GeneFamily | PWWP domain containing | 4.62e-05 | 22 | 58 | 3 | 1147 | |
| GeneFamily | Low density lipoprotein receptors | 7.71e-04 | 13 | 58 | 2 | 634 | |
| GeneFamily | LIM domain containing | 8.97e-04 | 59 | 58 | 3 | 1218 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.67e-03 | 19 | 58 | 2 | 360 | |
| GeneFamily | Ring finger proteins | 1.86e-03 | 275 | 58 | 5 | 58 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 2.67e-03 | 24 | 58 | 2 | 76 | |
| GeneFamily | Fibrinogen C domain containing | 2.89e-03 | 25 | 58 | 2 | 554 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.31e-03 | 34 | 58 | 2 | 487 | |
| GeneFamily | Phospholipases | 8.02e-03 | 42 | 58 | 2 | 467 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.44e-02 | 57 | 58 | 2 | 1179 | |
| GeneFamily | Fibronectin type III domain containing | 1.47e-02 | 160 | 58 | 3 | 555 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CCN5 RELN EYS FBN1 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 LTBP4 SSPOP FBN3 SVEP1 OTOG | 5.91e-18 | 196 | 72 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | CCN5 HSPG2 RELN EYS FBN1 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 LTBP4 SSPOP FBN3 SVEP1 OTOG | 3.38e-17 | 275 | 72 | 16 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CCN5 RELN FBN1 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 LTBP4 SSPOP SVEP1 OTOG | 5.27e-15 | 191 | 72 | 13 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | CCN5 HSPG2 RELN FBN1 TNC TNN LAMA1 LAMA3 LAMA5 LAMC3 LTBP4 SSPOP SVEP1 OTOG | 1.90e-14 | 270 | 72 | 14 | MM17057 |
| Coexpression | NABA_MATRISOME | SEMA3F CCN5 HSPG2 RELN EYS FBN1 MEGF6 MEGF8 TNC WNT1 TNN LAMA1 LAMA3 LAMA5 ADAM33 LAMC3 WNT4 LTBP4 SSPOP FBN3 SVEP1 OTOG | 2.44e-14 | 1026 | 72 | 22 | M5889 |
| Coexpression | NABA_MATRISOME | SEMA3F CCN5 HSPG2 RELN FBN1 MEGF6 MEGF8 TNC WNT1 TNN LAMA1 LAMA3 LAMA5 ADAM33 LAMC3 WNT4 LTBP4 SSPOP SVEP1 OTOG | 1.95e-12 | 1008 | 72 | 20 | MM17056 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | SEMA3F SLC16A5 MEGF6 MEGF8 NSD2 PLA2G3 NR0B1 LRP1 SLC39A4 LTBP4 DKK4 SLC16A8 NOTCH3 CRB1 ZC3HAV1 | 2.05e-08 | 909 | 72 | 15 | M41018 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.29e-08 | 40 | 72 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.45e-07 | 20 | 72 | 4 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.45e-07 | 23 | 72 | 4 | M48001 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SEMA3F RELN TRPM3 WNT1 DLL3 LAMA1 LRP2 UHRF1 LAMC3 WNT4 AJUBA TRIM14 SVEP1 ZC3HAV1 | 1.12e-06 | 1074 | 72 | 14 | M1941 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.47e-06 | 479 | 72 | 9 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.92e-06 | 483 | 72 | 9 | MM1082 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 1.51e-05 | 113 | 72 | 5 | M2291 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 1.72e-05 | 296 | 72 | 7 | M41675 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 1.83e-05 | 546 | 72 | 9 | M3837 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 2.47e-05 | 125 | 72 | 5 | MM1065 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 5.54e-05 | 27 | 72 | 3 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 5.54e-05 | 27 | 72 | 3 | MM1135 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 6.17e-05 | 493 | 72 | 8 | M1951 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 7.20e-05 | 504 | 72 | 8 | MM830 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 7.30e-05 | 505 | 72 | 8 | M39167 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 8.30e-05 | 261 | 72 | 6 | M1834 | |
| Coexpression | JONES_OVARY_NK_CELL | 1.07e-04 | 89 | 72 | 4 | M48353 | |
| Coexpression | FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP | 1.12e-04 | 90 | 72 | 4 | M48360 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.22e-04 | 35 | 72 | 3 | MM17054 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.97e-04 | 194 | 72 | 5 | M39122 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN | 2.27e-04 | 200 | 72 | 5 | M5088 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.27e-04 | 200 | 72 | 5 | M5930 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.46e-04 | 767 | 72 | 9 | M39209 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 3.04e-04 | 213 | 72 | 5 | M12176 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.07e-04 | 117 | 72 | 4 | M39300 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 3.20e-04 | 795 | 72 | 9 | M39050 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.95e-05 | 453 | 71 | 9 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.44e-05 | 466 | 71 | 9 | GSM777050_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 4.07e-05 | 189 | 71 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.90e-05 | 310 | 71 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | RELN SHC2 TRPM3 WNT1 DLL3 LAMA1 LRP2 WNT4 C7 FBN3 SVEP1 CRB1 | 9.56e-05 | 986 | 71 | 12 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.26e-04 | 450 | 71 | 8 | GSM777063_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.33e-04 | 337 | 71 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.77e-04 | 156 | 71 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.97e-04 | 480 | 71 | 8 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3 | 2.26e-04 | 89 | 71 | 4 | GSM791146_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 2.27e-04 | 768 | 71 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 2.29e-04 | 165 | 71 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 2.45e-04 | 496 | 71 | 8 | PCBC_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.45e-04 | 496 | 71 | 8 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.47e-04 | 373 | 71 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.49e-04 | 497 | 71 | 8 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 2.65e-04 | 783 | 71 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 2.93e-04 | 793 | 71 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_100 | 3.40e-04 | 99 | 71 | 4 | PCBC_ECTO_100 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_100 | 3.40e-04 | 99 | 71 | 4 | PCBC_ratio_DE_vs_SC_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 3.49e-04 | 41 | 71 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.61e-04 | 182 | 71 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 3.75e-04 | 284 | 71 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | SEMA3F LRRC3 RELN SHC2 MEGF6 TNC LAMA1 NR0B1 AIRE SSPOP DKK4 | 3.93e-04 | 982 | 71 | 11 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | SEMA3F LRRC3 HSPG2 RELN SHC2 SLC16A5 MEGF6 TNC LAMA1 NR0B1 ZDHHC8 FBN3 | 4.06e-04 | 1153 | 71 | 12 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | RELN IGFN1 FBN1 SHC2 TRPM3 WNT1 LAMA1 LRP2 AJUBA SSPOP SLC16A8 | 4.07e-04 | 986 | 71 | 11 | PCBC_ratio_ECTO_vs_SC_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.43e-04 | 293 | 71 | 6 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.06e-04 | 311 | 71 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.38e-04 | 437 | 71 | 7 | GSM777046_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 6.48e-04 | 207 | 71 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 7.03e-04 | 320 | 71 | 6 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 7.09e-04 | 445 | 71 | 7 | GSM777043_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 7.86e-04 | 54 | 71 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.87e-04 | 327 | 71 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 8.08e-04 | 455 | 71 | 7 | GSM777055_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.06e-04 | 336 | 71 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 9.49e-04 | 130 | 71 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.88e-04 | 471 | 71 | 7 | ratio_ECTO_vs_SC_1000_K3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-11 | 195 | 72 | 9 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-10 | 181 | 72 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-10 | 181 | 72 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.38e-10 | 193 | 72 | 8 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.38e-10 | 193 | 72 | 8 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-10 | 194 | 72 | 8 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-10 | 194 | 72 | 8 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-10 | 194 | 72 | 8 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-09 | 200 | 72 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-08 | 174 | 72 | 7 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-08 | 174 | 72 | 7 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-08 | 175 | 72 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-08 | 181 | 72 | 7 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-08 | 182 | 72 | 7 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-08 | 182 | 72 | 7 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.93e-08 | 183 | 72 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-08 | 184 | 72 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-08 | 184 | 72 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-08 | 184 | 72 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-08 | 184 | 72 | 7 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-08 | 184 | 72 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-08 | 185 | 72 | 7 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-08 | 188 | 72 | 7 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-08 | 188 | 72 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-08 | 188 | 72 | 7 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-08 | 189 | 72 | 7 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-08 | 189 | 72 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-08 | 190 | 72 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-08 | 191 | 72 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-08 | 191 | 72 | 7 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-08 | 192 | 72 | 7 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-08 | 192 | 72 | 7 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-08 | 192 | 72 | 7 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-08 | 192 | 72 | 7 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-08 | 192 | 72 | 7 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-08 | 192 | 72 | 7 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 193 | 72 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 193 | 72 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 193 | 72 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-08 | 193 | 72 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-08 | 194 | 72 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-08 | 195 | 72 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-08 | 195 | 72 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-08 | 195 | 72 | 7 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-08 | 195 | 72 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-08 | 196 | 72 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.10e-08 | 196 | 72 | 7 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-08 | 196 | 72 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-08 | 197 | 72 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-08 | 197 | 72 | 7 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-08 | 197 | 72 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-08 | 197 | 72 | 7 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.32e-08 | 198 | 72 | 7 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.32e-08 | 198 | 72 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-08 | 198 | 72 | 7 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.44e-08 | 199 | 72 | 7 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.44e-08 | 199 | 72 | 7 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.44e-08 | 199 | 72 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.44e-08 | 199 | 72 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.44e-08 | 199 | 72 | 7 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.44e-08 | 199 | 72 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.44e-08 | 199 | 72 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.44e-08 | 199 | 72 | 7 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.56e-08 | 200 | 72 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-08 | 200 | 72 | 7 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-08 | 200 | 72 | 7 | 57b9d6aa2265ab178a5886f36ecc66115bd382a8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-08 | 200 | 72 | 7 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.56e-08 | 200 | 72 | 7 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | (5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.56e-08 | 200 | 72 | 7 | 75e5ecb05e965e24d569aa2ef5cdf740b1528c06 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-08 | 200 | 72 | 7 | ddfbc004e7bd2fd3f11f046ed8fc049277160547 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.56e-08 | 200 | 72 | 7 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.56e-08 | 200 | 72 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.56e-08 | 200 | 72 | 7 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-07 | 144 | 72 | 6 | cf9f049ab6cd80521598124f057c2debdde24788 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-07 | 144 | 72 | 6 | 41eaeca54b3c39de417597267cbdb1f195dd885a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-07 | 164 | 72 | 6 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-07 | 168 | 72 | 6 | 11ab08e373abe4bbd0f2134db38a2e8efa0eb159 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-07 | 169 | 72 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 169 | 72 | 6 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-07 | 171 | 72 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-07 | 171 | 72 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-07 | 171 | 72 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-07 | 177 | 72 | 6 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.58e-07 | 179 | 72 | 6 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.58e-07 | 179 | 72 | 6 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| Computational | Ovary genes. | 2.52e-05 | 368 | 47 | 9 | MODULE_1 | |
| Computational | Adhesion molecules. | 3.16e-05 | 141 | 47 | 6 | MODULE_122 | |
| Computational | Placenta genes. | 1.49e-04 | 463 | 47 | 9 | MODULE_38 | |
| Computational | Trachea genes. | 3.86e-04 | 415 | 47 | 8 | MODULE_6 | |
| Drug | kalinin | 1.90e-08 | 55 | 71 | 6 | CID000032518 | |
| Drug | AC1L1G72 | 2.82e-08 | 11 | 71 | 4 | CID000003553 | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.82e-07 | 197 | 71 | 8 | 2241_UP | |
| Drug | Sikvav | 8.80e-07 | 24 | 71 | 4 | CID005487517 | |
| Drug | AC1L9INI | 1.12e-06 | 59 | 71 | 5 | CID000445839 | |
| Drug | AC1L1B58 | 1.94e-06 | 29 | 71 | 4 | CID000001288 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 2107_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 4133_DN | |
| Drug | 2-amino-5-methylpyridine | 4.24e-06 | 77 | 71 | 5 | CID000015348 | |
| Drug | Calcort | 5.91e-06 | 38 | 71 | 4 | CID000026709 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 6.14e-06 | 83 | 71 | 5 | CID011968896 | |
| Drug | NSC 714187 | 6.91e-06 | 85 | 71 | 5 | CID005288693 | |
| Drug | H-9 dihydrochloride | 9.14e-06 | 90 | 71 | 5 | CID000003544 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.47e-05 | 169 | 71 | 6 | 6064_DN | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 2.08e-05 | 373 | 71 | 8 | ctd:C540355 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.17e-05 | 181 | 71 | 6 | 6951_DN | |
| Drug | AC1L1C2F | 2.43e-05 | 110 | 71 | 5 | CID000001711 | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.61e-05 | 187 | 71 | 6 | 7183_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 6368_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 4221_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 3686_DN | |
| Drug | CC270 | 3.47e-05 | 59 | 71 | 4 | CID006918852 | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 6814_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 5729_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 7549_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 1238_DN | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 5984_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 6201_UP | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 5539_UP | |
| Drug | LG 5 | 3.71e-05 | 60 | 71 | 4 | CID011840957 | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A | 3.80e-05 | 200 | 71 | 6 | 3682_DN | |
| Drug | Mustard Gas | RELN FBN1 TNC NSD2 WNT1 PLA2G3 LAMA1 LAMA3 LAMA5 UHRF1 C7 DKK4 NOTCH3 DNMT3A | 5.75e-05 | 1341 | 71 | 14 | ctd:D009151 |
| Drug | dysprosium | 8.47e-05 | 74 | 71 | 4 | CID000023912 | |
| Drug | Rgd Peptide | 1.02e-04 | 239 | 71 | 6 | CID000104802 | |
| Drug | YIGSR | 1.09e-04 | 79 | 71 | 4 | CID000123977 | |
| Drug | quinocetone | 1.25e-04 | 248 | 71 | 6 | ctd:C502851 | |
| Drug | I-Q-S | 1.28e-04 | 156 | 71 | 5 | CID000003540 | |
| Drug | 1,2-dimethylhydrazine | 1.52e-04 | 86 | 71 | 4 | CID000001322 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.02e-04 | 172 | 71 | 5 | 5209_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.02e-04 | 172 | 71 | 5 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.02e-04 | 172 | 71 | 5 | 2794_DN | |
| Drug | LMWH | 2.12e-04 | 663 | 71 | 9 | CID000000772 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.13e-04 | 174 | 71 | 5 | 3462_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 2.19e-04 | 175 | 71 | 5 | 1161_DN | |
| Drug | Ikvav | 2.27e-04 | 38 | 71 | 3 | CID000131343 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 2.51e-04 | 98 | 71 | 4 | ctd:C014175 | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.76e-04 | 184 | 71 | 5 | 4205_UP | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.76e-04 | 184 | 71 | 5 | 6939_DN | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.05e-04 | 188 | 71 | 5 | 5490_UP | |
| Drug | Iohexol [66108-95-0]; Down 200; 4.8uM; HL60; HT_HG-U133A | 3.05e-04 | 188 | 71 | 5 | 2461_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.20e-04 | 190 | 71 | 5 | 1056_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 4094_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 6498_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 5456_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 2123_UP | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 3.36e-04 | 192 | 71 | 5 | 1829_UP | |
| Drug | coprogen | 3.40e-04 | 9 | 71 | 2 | CID006323272 | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 4321_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 4286_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 1464_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 3262_UP | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 3197_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 7214_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 3194_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6727_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6827_UP | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 5293_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 2789_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6696_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.52e-04 | 194 | 71 | 5 | 1024_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 3422_UP | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2064_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 2478_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 4180_DN | |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 4781_UP | |
| Drug | 15d-PGJ2; Up 200; 10uM; SKMEL5; HG-U133A | 3.61e-04 | 195 | 71 | 5 | 564_UP | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 5771_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 2229_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 3847_UP | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4257_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 1821_DN | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4963_UP | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6673_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4826_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6435_UP | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 3530_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 6832_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 4381_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 5979_UP | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 3.69e-04 | 196 | 71 | 5 | 7346_DN | |
| Drug | LY294002; Up 200; 10uM; ssMCF7; HG-U133A | 3.78e-04 | 197 | 71 | 5 | 401_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 4668_UP | |
| Drug | troglitazone; Up 200; 10uM; SKMEL5; HG-U133A | 3.78e-04 | 197 | 71 | 5 | 504_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6867_UP | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 7149_DN | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6714_UP | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 3572_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; HL60; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 2445_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6811_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.78e-04 | 197 | 71 | 5 | 6829_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.71e-05 | 3 | 71 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.01e-04 | 447 | 71 | 7 | C3714756 | |
| Disease | X-linked Adrenal Hypoplasia | 1.58e-04 | 8 | 71 | 2 | C0342482 | |
| Disease | aortic aneurysm | 2.54e-04 | 10 | 71 | 2 | EFO_0001666 | |
| Disease | Microphthalmos | 3.10e-04 | 11 | 71 | 2 | C0026010 | |
| Disease | cortical surface area measurement | RELN FBN1 MEGF6 TUT7 TRIM8 UHRF1 LAMC3 WNT4 AJUBA FBN3 SVEP1 | 3.51e-04 | 1345 | 71 | 11 | EFO_0010736 |
| Disease | Migraine Disorders | 4.38e-04 | 13 | 71 | 2 | C0149931 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 5.10e-04 | 14 | 71 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | inositol measurement | 5.10e-04 | 14 | 71 | 2 | EFO_0010504 | |
| Disease | Craniofacial Abnormalities | 5.55e-04 | 156 | 71 | 4 | C0376634 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 6.70e-04 | 16 | 71 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 6.70e-04 | 16 | 71 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 6.70e-04 | 16 | 71 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 6.70e-04 | 16 | 71 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 6.70e-04 | 16 | 71 | 2 | C3541456 | |
| Disease | Van Buchem disease | 7.58e-04 | 17 | 71 | 2 | C0432272 | |
| Disease | Dyschondroplasias | 9.51e-04 | 19 | 71 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 9.51e-04 | 19 | 71 | 2 | C0029422 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.05e-03 | 20 | 71 | 2 | C0026760 | |
| Disease | Autism Spectrum Disorders | 1.14e-03 | 85 | 71 | 3 | C1510586 | |
| Disease | Squamous cell carcinoma of esophagus | 1.58e-03 | 95 | 71 | 3 | C0279626 | |
| Disease | Dwarfism | 1.65e-03 | 25 | 71 | 2 | C0013336 | |
| Disease | systemic mastocytosis | 1.65e-03 | 25 | 71 | 2 | MONDO_0016586 | |
| Disease | pulse pressure measurement | 1.77e-03 | 1392 | 71 | 10 | EFO_0005763 | |
| Disease | Encephalopathies | 1.93e-03 | 27 | 71 | 2 | C0085584 | |
| Disease | Sezary Syndrome | 1.93e-03 | 27 | 71 | 2 | C0036920 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.93e-03 | 27 | 71 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.07e-03 | 28 | 71 | 2 | DOID:5409 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCFCVECVDLLVGPG | 556 | Q9Y6K1 | |
| EEGCCCFPLDGHLLC | 506 | Q96IF1 | |
| LRPGAQCAHGDCCVR | 451 | Q9BZ11 | |
| PEHGFCEQPGECRCL | 226 | Q9NYJ7 | |
| DECIVSGGLCHLGRC | 491 | Q75N90 | |
| GELICCDGCPRAFHL | 306 | O43918 | |
| EPCLHGGTCQGTRCL | 4151 | P98160 | |
| GFLLLGGLLLHCCAC | 176 | O95907 | |
| PICDCLGFGICRGID | 601 | Q5SY16 | |
| HPGCFRCELCDVELA | 96 | Q7Z4I7 | |
| ICVDGPGHTFDCRCL | 1136 | Q5T1H1 | |
| EICDAHGRCLCRPGV | 501 | Q16787 | |
| GCHTDEFQCRLDGLC | 1061 | Q07954 | |
| PCRCPDHAGAVAVFC | 36 | Q9BY71 | |
| LCEGPCCGAFHLACL | 681 | O96028 | |
| ECRVGEPCRHGGTCL | 161 | Q9UM47 | |
| CRSQPCRHGGKCLDL | 586 | Q9UM47 | |
| DCLQDPGGGFRCLCH | 1221 | Q9UM47 | |
| CLQAVGHECDCGLLR | 311 | P23743 | |
| CRCEPGFLGRACDLH | 191 | Q7Z7M0 | |
| CGLHRCEEPCHRGNC | 721 | Q12986 | |
| CPNHRCIDLSFVCDG | 1156 | P98164 | |
| FHGREGNCPLTCDLC | 551 | Q9NQV6 | |
| LCQPEFAGPHCDRCR | 606 | O15230 | |
| LFLGRCVPCQCHGHS | 1856 | O15230 | |
| RGHGDCLREQCICDP | 2861 | P78509 | |
| CCFCGKDHPRQGSIL | 66 | P51843 | |
| RCCFCGEDHPRQGSI | 131 | P51843 | |
| LRTFDCGPGLCCARH | 146 | Q9UBT3 | |
| ECQRDPLLCRGGVCH | 1116 | P35555 | |
| CHNLPGLFRCECEIG | 1461 | P35555 | |
| EGPLVHVACCCGNIL | 281 | P51795 | |
| EFDPCHCRPCQNGGL | 451 | P10643 | |
| CARRLGEPCDQLHVC | 56 | O76076 | |
| ICHNGGVCVKPDRCL | 156 | Q8N2S1 | |
| VGLRSHLLPQGCECC | 1161 | Q86VF2 | |
| HCVCLPGFHGRDCER | 116 | Q6UY11 | |
| CDCHRPYEGPNCLRE | 696 | P82279 | |
| CRLGLCCHLGSVQGE | 211 | Q6ZN32 | |
| GCACPQGLLRHGDAC | 926 | Q6ZRI0 | |
| CLNGGLCDPHTGRCL | 1091 | O75095 | |
| IGRICLNDDGGHCCL | 296 | Q13275 | |
| PDGCNHCTCLEGRLN | 3386 | A2VEC9 | |
| DGILFGGICQPCECH | 731 | P25391 | |
| LADRVHCANGPCGKC | 51 | Q6P5W5 | |
| LPCGHSLCRGCAQRA | 81 | Q8NCN4 | |
| LLCCGTCPRVFHEDC | 546 | Q9HB58 | |
| LNGGKCVRPNRCHCL | 3541 | Q4LDE5 | |
| GPDLCCREHDRCPQN | 176 | Q9NZ20 | |
| QGCYPLDGHILCKAC | 446 | Q15654 | |
| GLACAGFCCHQLLLI | 196 | Q8N966 | |
| GGIFLHCCICGAIIR | 176 | O15375 | |
| IIRGFCHLCDGQEAC | 86 | P08559 | |
| DPISLDCGHDFCIRC | 66 | Q9ULX5 | |
| PINQRACHILECCEG | 271 | P98077 | |
| CVDGRCLCHEPYVGA | 181 | Q9UQP3 | |
| CHGCVPDLALVLRGC | 181 | A6NJB7 | |
| TKDPHRCCCGRLIGQ | 81 | Q9HCF6 | |
| PGNCHLRGRCIDGQC | 191 | P24821 | |
| VEGCLQCLDVCGHPR | 41 | Q5BKY6 | |
| CAPLHAEVFCRAGLC | 116 | Q6ZVL8 | |
| PCEFRLGCGHVCTRA | 1291 | Q9P2E3 | |
| RCVCALCPVLGAHRG | 41 | Q14142 | |
| CACHLCGGRQDPDKQ | 316 | Q96T88 | |
| CHLPGEVLICDLCFR | 106 | Q15326 | |
| ALDGCELLCCGRGHR | 321 | P04628 | |
| NGCFPLDGHVLCRKC | 551 | Q15942 | |
| CELLCCGRGFHTAQV | 306 | P56705 | |
| PFTRGCCGNVEHVLC | 231 | Q9ULC8 | |
| HCENCGICRIGPKED | 101 | Q96PM5 | |
| EICLDHLCKGCPLNG | 511 | Q7Z2W4 | |
| LCCVAFCLLGAGPVD | 6 | A0A0B4J1U6 | |
| APNDRCCRICGKIGH | 1341 | Q5VYS8 | |
| VQLPCKHNFCRGCIG | 26 | Q9BZR9 | |
| HRVPGLTCCGRDQVC | 216 | O14939 | |
| ELVPGERLFCCLFCG | 2796 | Q6ZQQ6 | |
| CPECGRGFCQRSDLI | 236 | Q14929 | |
| CALCNCGEPSLHGQR | 66 | O14686 | |
| VGNCDPLSGHCLRCL | 821 | Q9Y6N6 | |
| FDLQPGRGCRSCKCH | 906 | Q9Y6N6 |